Histopathology of Uveal Malignant Melanoma and Other Uveal Tumors

  • Carol L. Shields
  • Jerry A. Shields
Part of the Medical Radiology book series (MEDRAD)


The size of the normal globe can vary, but it usually averages about 24 mm in diameter. The wall of the eye is composed of three ocular coats (Fig. 2.1). The outermost coat is fibrous and consists of the cornea and sclera. The middle, or vascular coat, is known as the uveal tract and consists of the iris, ciliary body, and choroid. The innermost, or sensory, coat consists of the retina and optic nerve head. The intraocular portion of the globe also may be divided anatomically into two main cavities: the aqueous cavity, consisting of the anterior and posterior chambers, and the vitreous cavity. Most intraocular tumors arise from the uveal tract; less commonly they originate from the retina or optic disk.


Retinal Pigment Epithelium Ciliary Body Uveal Melanoma Choroidal Melanoma Melanocytic Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Brown GC, Shields JA, Augsburger JJ, Serota FT, Koch P (1981) Leukemic optic neuropathy. Int Ophthalmol 3:111–116PubMedCrossRefGoogle Scholar
  2. Callender GR (1931) Malignant melanotic tumors of the eye: a study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 36:131–142Google Scholar
  3. Char DH, Margolis L, Newman AB (1981) Ocular reticulum cell sarcoma. Am J Ophthalmol 91:480–483PubMedGoogle Scholar
  4. Cutler SJ, Young JL Jr (1975) Third National Cancer Survey. Incidence Data, NCI Monograph no. 41. Government Printing Office, Washington, DCGoogle Scholar
  5. Einhorn LH, Burgess MA, Gottleib JA (1974) Metastatic patterns of choroidal melanoma. Cancer 34:1001–1004PubMedCrossRefGoogle Scholar
  6. Ferry AP, Font RL (1974) Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases. Arch Ophthalmol 92:276–286PubMedCrossRefGoogle Scholar
  7. Ganley JP, Comstock GW (1973) Benign nevi and malignant melanomas of the choroid. Am J Ophthalmol 76:19–25PubMedGoogle Scholar
  8. Knowles DM, II, Jakobiec FA (1981) Quantitative determination of T cells in ocular lymphoid infiltrates: an indirect method for distinguishing between pseudo-lymphomas and malignant lymphomas. Arch phthalmol 99:309–316CrossRefGoogle Scholar
  9. McLean IW, Foster WD, Zimmerman LE (1977) Prognostic factors in small malignant melanomas of the choroid and ciliary body. Arch Ophthalmol 95:48–58PubMedCrossRefGoogle Scholar
  10. McLean IW, Zimmerman LE, Evans RE (1978) Reappraisal of Callender’s spindle A type of malignant melanoma of the choroid and ciliary body. Am J Ophthalmol 86:557–564PubMedGoogle Scholar
  11. Naumann G, Yanoff Y, Zimmerman LE (1966) Histogenesis of malignant melanomas of the uvea. I. Histopathologic characteristics of nevi of the choroid and ciliary body. Arch Ophthalmol 76:784–796PubMedCrossRefGoogle Scholar
  12. Shammas HF, Blodi FC (1977) Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 95:63–69PubMedCrossRefGoogle Scholar
  13. Shields CL, Shields JA (1989) Reasons for enucleation following plaque radiotherapy: clinical findings. Ophthalmology 96:919–924PubMedGoogle Scholar
  14. Shields CL, Shields JA, Karlsson LL, Menduke H, Brady LW (1990) Enucleation following plaque radiotherapy for posterior uveal melanoma: histopathologic findings. Ophthalmology 97:1665–1670PubMedGoogle Scholar
  15. Shields JA (1977) Current approaches to the diagnosis and management of choroidal melanomas. Surv Ophthalmol 21:443–463PubMedCrossRefGoogle Scholar
  16. Shields JA (1983) Diagnosis and management of intraocular tumors. C.V. Mosby, St. LouisGoogle Scholar
  17. Shields JA, Federman JL (1979) Malignant melanoma of the uveal tract. In: Clark WH, Goldman LI, Mastrangelo MJ (eds) Human malignant melanoma. Grune & Stratton, New YorkGoogle Scholar
  18. Shields JA, Zimmerman LE (1973) Lesions simulating malignant melanomas of the posterior uvea. Arch Ophthalmol 89:466–471PubMedCrossRefGoogle Scholar
  19. Shields JA, Augsburger JJ, Brown GC, Stephens RF (1980) The differential diagnosis of posterior uveal melanoma. Ophthalmology 87:543–548PubMedGoogle Scholar
  20. Shields JA, Augsburger JJ, Gonder JR, McLeod D (1981) Localized benign lymphoid tumor of the iris. Arch Ophthalmol 99:2147–2148PubMedCrossRefGoogle Scholar
  21. Shields JA, Sanborn GE, Augsburger JJ, Klein RM (1983) Adenoma of the iris pigment epithelium. Ophthalmology 90:735–739PubMedGoogle Scholar
  22. Stephens RF, Shields JA (1979) Diagnosis and management of cancer metastatic to the uvea. A study of 70 cases. Ophthalmology 86:1336–1349PubMedGoogle Scholar
  23. Territo C, Shields CL, Shields JA, Schroeder RP, Augsburger J J (1988) Natural course of melanocytic tumors of the iris. Ophthalmology 95:1251–1255PubMedGoogle Scholar
  24. Wilkes SR, Robertson DM, Kurland LT, Cambell JR (1979) Incidence of uveal malignant melanoma in the resident population of Rochester and Olmsted County, Minnesota. Am J Ophthalmol 87:639–641PubMedGoogle Scholar
  25. Zimmerman LE (1972) Histopathologic considerations in the management of tumors of the iris and ciliary body. Ann Inst Barraquer 10:27–57Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • Carol L. Shields
    • 1
  • Jerry A. Shields
    • 1
  1. 1.Oncology Service, Willis Eye HospitalThomas Jefferson UniversityPhiladelphiaUSA

Personalised recommendations